Alphyn Biologics Achieves Milestone in Phase 2 Trial for Skin Disorder Treatment Alphyn Biologics has successfully enrolled participants in its Phase 2 trial for Zabalafin Hydrogel, a promising treatment for molluscum contagiosum.

Alphyn Biologics Achieves Milestone in Phase 2 Trial for Skin Disorder Treatment #USA #Annapolis #Zabalafin_Hydrogel #Alphyn_Biologics #Molluscum_Contagiosum

Alphyn Biologics Initiates Phase 2 Trial for Promising Treatment of Molluscum Contagiosum Alphyn Biologics has started its Phase 2 clinical trial for Zabalafin Hydrogel, targeting Molluscum Contagiosum in young patients. This therapy aims to redefine treatment options.

Alphyn Biologics Initiates Phase 2 Trial for Promising Treatment of Molluscum Contagiosum #USA #Annapolis #Zabalafin_Hydrogel #Alphyn_Biologics #Molluscum_Contagiosum